Cardiac Perfusion Solution Recalled for Sterility Assurance Issues
Central Admixture Pharmacy Services is recalling Modified del Nido Microplegia syringes after an FDA inspection raised concerns about their sterility. Approximately 690 syringes distributed nationwide may be affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for suspected sterility failure in a product intended for surgical use. No illnesses or injuries have been reported; the hazard remains theoretical, placing this in the High category per the severity rubric.
Plain-English summary
Modified del Nido Microplegia, a cardiac perfusion solution used in heart surgery, is being recalled by Central Admixture Pharmacy Services, Inc. The recall was initiated after an FDA inspection questioned the sterility of the product, which is meant to be sterile for surgical use.
Approximately 690 syringes were distributed nationwide in 40 mL units. The affected product (NDC 71285-0219-1) includes the following lot numbers and expiration dates: Lot 37-893821 (Exp 04/28/2023); 37-894813 and 37-894815 (Exp 04/30/2023); 37-895489 and 37-895490 (Exp 05/05/2023); 37-897810 and 37-897811 (Exp 05/13/2023); and 37-899585 (Exp 05/20/2023).
This recall affects healthcare facilities and providers nationwide. Anyone with affected syringes should verify inventory against the lot numbers and expiration dates listed above and refrain from using affected units.
The recalled product
- Product
- Modified del Nido Microplegia, packaged in 40 mL per syringe, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA 18106, NDC 71285-0219-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Affected units
- 690
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (13)
- Lot # 37-893821
- Exp 04/28/2023
- 37-894813
- 37-894815
- Exp 04/30/2023
- 37-895489
- 37-895490
- Exp 05/05/2023
- 37-897810
- 37-897811
- Exp 05/13/2023
- 37-899585
- Exp 05/20/2023
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 108 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 108 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · contamination risk
See all →- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Vancomycin Injection Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- HighIntramedullary Bone Saw Blade Assembly Recall for Packaging Damage
FDA (Devices) · 2026-08-12
- SevereMedical Convenience Kits Recalled Over Lidocaine Injection Supplier Quality Issues
FDA (Devices) · 2026-08-05